An interventional study of Delivery in Preeclampsia, sponsored by Complejo Hospitalario Dr. Arnulfo Arias Madrid. Completed at 8 sites in 6 countries. Open to female participants, including healthy volunteers. Per ClinicalTrials.gov, last updated 2012-08-14.
Sponsored by Complejo Hospitalario Dr. Arnulfo Arias Madrid · Not applicable, Interventional, and Supportive care
How best to manage preeclampsia remote from term is controversial because of conflicting maternal and neonatal risks. Gestational age is the most important determinant of neonatal outcome. There are two basic approaches when delivery is not clear indicated by assessment of maternal and fetal well-being. The interventionist care when the delivery is planned within 48 hours and the expectant care which refers to pregnancy prolongation during which time women and fetuses are carefully monitored for indications for delivery.
The purpose of this study is to evaluate maternal and perinatal outcomes with expectant vs interventionist or aggressive management of severe preeclampsia at 28 to 33 weeks of gestation.
Severa Preeclampsia between 28 and 33 weeks of gestation Women and fetus with stable condition All women receive complete dosis of steroids
916 studies on the registry are indexed under Pre-Eclampsia; 243 are open to participants now.
This study's enrollment of 264 is above the median of 110 across 480 interventional studies indexed under Pre-Eclampsia.
Browse Pre-Eclampsia studies →Complejo Hospitalario Dr. Arnulfo Arias Madrid is the lead sponsor of 5 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Expectant management: refers to pregnancy prolongation during which time women and fetuses are carefully monitored for indications for delivery.
Interventionist management: in which blood pressure is stabilized, corticosteroids are given for acceleration of fetal maturity and delivery is planned within 48-72 hours.
Procedure: Delivery
Termination of pregnancy (delivery)after completed corticosteroids
Also known as: Severe preeclampsia, expectant management of severe preeclampsia
Perinatal death
Number of perinatal in each group (interventionist or expectant management)
Time frame: After begining the randomization until 4 weeks after delivery.
Perinatal complications and maternal complications
Time frame: Maternal and perinatal complication after begining the randomization until 4 weeks after delivery.
This study is completed, as verified in Aug 2012. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Complejo Hospitalario Dr. Arnulfo Arias Madrid